107 related articles for article (PubMed ID: 23390083)
1. EpCAM-associated claudin-7 supports lymphatic spread and drug resistance in rat pancreatic cancer.
Thuma F; Zöller M
Int J Cancer; 2013 Aug; 133(4):855-66. PubMed ID: 23390083
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.
Thuma F; Heiler S; Schnölzer M; Zöller M
Oncotarget; 2016 May; 7(21):30659-77. PubMed ID: 27120791
[TBL] [Abstract][Full Text] [Related]
3. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
[TBL] [Abstract][Full Text] [Related]
4. The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities.
Heiler S; Mu W; Zöller M; Thuma F
Cell Commun Signal; 2015 Jun; 13():29. PubMed ID: 26054340
[TBL] [Abstract][Full Text] [Related]
5. Tspan8 and CD151 promote metastasis by distinct mechanisms.
Yue S; Mu W; Zöller M
Eur J Cancer; 2013 Sep; 49(13):2934-48. PubMed ID: 23683890
[TBL] [Abstract][Full Text] [Related]
6. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract][Full Text] [Related]
7. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
[TBL] [Abstract][Full Text] [Related]
8. The metastasis-associated molecule C4.4A promotes tissue invasion and anchorage independence by associating with the alpha6beta4 integrin.
Thuma F; Ngora H; Zöller M
Mol Oncol; 2013 Oct; 7(5):917-28. PubMed ID: 23727360
[TBL] [Abstract][Full Text] [Related]
9. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
Yue S; Mu W; Erb U; Zöller M
Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
[TBL] [Abstract][Full Text] [Related]
10. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
[TBL] [Abstract][Full Text] [Related]
11. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M
Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117
[TBL] [Abstract][Full Text] [Related]
12. CD44v6 dependence of premetastatic niche preparation by exosomes.
Jung T; Castellana D; Klingbeil P; Cuesta Hernández I; Vitacolonna M; Orlicky DJ; Roffler SR; Brodt P; Zöller M
Neoplasia; 2009 Oct; 11(10):1093-105. PubMed ID: 19794968
[TBL] [Abstract][Full Text] [Related]
13. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
Ladwein M; Pape UF; Schmidt DS; Schnölzer M; Fiedler S; Langbein L; Franke WW; Moldenhauer G; Zöller M
Exp Cell Res; 2005 Oct; 309(2):345-57. PubMed ID: 16054130
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAM.
Kyuno D; Zhao K; Bauer N; Ryschich E; Zöller M
Transl Oncol; 2019 Feb; 12(2):191-199. PubMed ID: 30393102
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
16. CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.
Jung T; Gross W; Zöller M
J Biol Chem; 2011 May; 286(18):15862-74. PubMed ID: 21372142
[TBL] [Abstract][Full Text] [Related]
17. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.
Gesierich S; Paret C; Hildebrand D; Weitz J; Zgraggen K; Schmitz-Winnenthal FH; Horejsi V; Yoshie O; Herlyn D; Ashman LK; Zöller M
Clin Cancer Res; 2005 Apr; 11(8):2840-52. PubMed ID: 15837731
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant isoforms associate with tetraspanins and EpCAM.
Schmidt DS; Klingbeil P; Schnölzer M; Zöller M
Exp Cell Res; 2004 Jul; 297(2):329-47. PubMed ID: 15212938
[TBL] [Abstract][Full Text] [Related]
19. EpCAM in carcinogenesis: the good, the bad or the ugly.
van der Gun BT; Melchers LJ; Ruiters MH; de Leij LF; McLaughlin PM; Rots MG
Carcinogenesis; 2010 Nov; 31(11):1913-21. PubMed ID: 20837599
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
